AbbVie, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
AbbVie, Inc. is a biopharmaceutical company that specializes in pharmaceutical research and drug manufacturing. Its medications treat autoimmune diseases, cancers, HIV/AIDS, and arthritis, among other conditions.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
AbbVie creates positive Humankind Value on the whole. Considerable positive value is associated with its Healthcare R&D ($356.5 B), Pharmaceuticals ($121.4 B), and Economic Value ($11.6 B). Healthcare is a central component in how we measure Humankind Value because a large contribution to modern life expectancies has come from the last 150 years of medical innovation. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. AbbVie is among the top ten companies for both Healthcare R&D and Pharmaceuticals out of the companies we have analyzed. Positive value from these two categories includes the impact of an estimated 9,914,591.2 additional years lived by people worldwide. The Humankind Value of this company could improve with reductions in Greenhouse Gases (-$3.1 B) and improvements in its impact on Opioid Abuse (-$2.1 B). Healthcare R&D, Pharmaceuticals, Economic Value, Greenhouse Gases, and Opioid Abuse are attached to this company as a result of its direct business activities.